+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Netherlands Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

  • PDF Icon

    Report

  • 49 Pages
  • October 2023
  • Region: Netherlands
  • MarketLine
  • ID: 5782134
Description Jump to:
Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Dutch pharmaceuticals market had total revenues of $6.0 billion in 2022, representing a compound annual growth rate (CAGR) of 2.9% between 2017 and 2022.
  • 0
  • According to in-house research, in 2022, Germany accounted for 1.7% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Dutch stood at 6.2% of total health spending in 2021.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the Netherlands
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts

Reasons to Buy

  • What was the size of the Netherlands pharmaceuticals market by value in 2022?
  • What will be the size of the Netherlands pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
  • How has the market performed over the last five years?
  • What are the main segments that make up the Netherlands's pharmaceuticals market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 Company Profiles
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. GSK plc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher
List of Tables
Table 1: Netherlands pharmaceuticals market value: $ billion, 2017-22
Table 2: Netherlands pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Netherlands pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: Annual Financial Ratios
Table 10: Pfizer Inc.: Key Employees
Table 11: Pfizer Inc.: Key Employees Continued
Table 12: AstraZeneca PLC: key facts
Table 13: AstraZeneca PLC: Annual Financial Ratios
Table 14: AstraZeneca PLC: Key Employees
Table 15: AstraZeneca PLC: Key Employees Continued
Table 16: GSK plc.: key facts
Table 17: GSK plc.: Annual Financial Ratios
Table 18: GSK plc.: Key Employees
Table 19: GSK plc.: Key Employees Continued
Table 20: Netherlands size of population (million), 2018-22
Table 21: Netherlands gdp (constant 2005 prices, $ billion), 2018-22
Table 22: Netherlands gdp (current prices, $ billion), 2018-22
Table 23: Netherlands inflation, 2018-22
Table 24: Netherlands consumer price index (absolute), 2018-22
Table 25: Netherlands exchange rate, 2018-22
List of Figures
Figure 1: Netherlands pharmaceuticals market value: $ billion, 2017-22
Figure 2: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Netherlands pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in the Netherlands, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis AG
  • Pfizer Inc.
  • AstraZeneca PLC
  • GSK plc.

Related Topics

Related Reports

Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027 - Product Image

Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

  • Report
  • 50 Pages
  • Europe
From
G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 - Product Image

G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

  • Report
  • 228 Pages
  • Global
From
Global Angina Pectoris Drugs Market by Type (Prinzmetal Angina, Stable Angina, Unstable Angina), Drugs (Anti-Ischemic Agents, Antihypertensive Agents, Antiplatelet Agents), Route of Administration, Distribution Channel, End-Users - Forecast 2024-2030 - Product Image

Global Angina Pectoris Drugs Market by Type (Prinzmetal Angina, Stable Angina, Unstable Angina), Drugs (Anti-Ischemic Agents, Antihypertensive Agents, Antiplatelet Agents), Route of Administration, Distribution Channel, End-Users - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030 - Product Image

Global Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Ethical Pharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Ethical Pharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 102 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.